MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with H

Hyoscine butylbromide

Hyoscine butylbromide 10mg tablets

Use with caution

Stability notes for Hyoscine butylbromide 10mg tablets

Protect from light, protect from moisture.

Provenance

This compatibility recommendation is derived from Buscopan 10mg tablets (Sanofi).

Suppliers (12) of Hyoscine butylbromide 10mg tablets
Buscopan 10mg tablets (Opella POM UK Ltd)
Buscopan 10mg tablets (Sigma Pharmaceuticals Plc)
Buscopan Cramps 10mg tablets (Opella Healthcare UK Ltd)
Buscopan IBS Relief 10mg tablets (Opella Healthcare UK Ltd)
Hyoscine butylbromide 10mg tablets (A A H Pharmaceuticals Ltd)
Hyoscine butylbromide 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Hyoscine butylbromide 10mg tablets (Medihealth (Northern) Ltd)
Hyoscine butylbromide 10mg tablets (Morningside Healthcare Ltd)
Hyoscine butylbromide 10mg tablets (Ria Generics Ltd)
Sigmopan 10mg tablets (Ria Generics Ltd)
Sigmopan Cramps Relief 10mg tablets (Ria Generics Ltd)
Sigmopan IBS Relief 10mg tablets (Ria Generics Ltd)

Hyoscine butylbromide 20mg tablets

No stability information

Stability notes for Hyoscine butylbromide 20mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Hyoscine butylbromide 20mg tablets
Hyoscine butylbromide 20mg tablets (A A H Pharmaceuticals Ltd)
Hyoscine butylbromide 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Hyoscine butylbromide 20mg tablets (Medihealth (Northern) Ltd)
Hyoscine butylbromide 20mg tablets (Morningside Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.